세계의 임상시험 공급 및 물류 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, Phase별, 치료 영역별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Clinical Trial Supply And Logistics Market Size, Share & Trends Analysis Report By Service, By Phase, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,704,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,167,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,093,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

임상시험 공급 및 물류 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 임상시험 공급 및 물류 시장 규모는 2030년까지 67억 2,000만 달러에 달하고, 2025-2030년 7.97%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예측됩니다.

임상시험 공급 및 물류 시장의 첨단 기술 및 혁신의 부상, 엄격한 규제 시행, 코로나19와 같은 전염병의 확산으로 인한 임상시험 수요 증가가 그 배경이 되고 있습니다.

초기에는 코로나19 팬데믹으로 인해 공급망의 혼란과 바이러스 확산을 막기 위한 정부의 민간 항공사 감축으로 인해 시장에 부정적인 영향을 미쳤습니다. 그러나 이 질병을 예방하기 위한 코로나19 백신에 대한 수요가 증가함에 따라 시장은 빠르게 회복되어 크게 성장하기 시작했습니다. 예를 들어, WHO에 따르면 2022년 8월 2일 현재 임상 개발 Phase에 있는 백신은 169종, 전임상 Phase에 있는 백신은 198종에 달할 전망입니다.

임상시험 용품 공급업체들공급망 관리 소프트웨어에 대한 투자는 매우 활발하게 이루어지고 있습니다. 임상시험의 복잡성과 시장 경쟁의 심화는 공급망 관리에 새로운 기술을 도입하는 요인으로 작용하고 있습니다. 업계 업체들의 신기술 도입이 증가함에 따라 재고 관리, 공급망 계획, 보조 공급망 관리를 위한 소프트웨어에 대한 수요가 증가할 것으로 예측됩니다.

임상시험 공급 및 물류 시장 보고서 하이라이트

• 서비스 분야에서는 물류 및 유통이 2024년 25.3% 시장 점유율을 차지했습니다. 이는 코로나19 사태로 인한 임상시험 증가에 기인합니다.
• Phase별로는 Phase III가 2024년 가장 큰 매출 점유율을 차지했습니다.
• 치료 영역별로는 심혈관 질환 부문이 2024년 가장 큰 시장 점유율을 차지했습니다. 이는 시장에 새로움과 혁신을 가져오기 위한 시장 진출기업들의 투자 증가에 기인한 것으로 분석됩니다.
• 북미는 2024년 매출 점유율 38.33%를 차지하며 시장을 주도했습니다. 이 지역은 전체 지역 중 가장 많은 임상시험이 진행되어 임상시험 공급 및 물류 시장 성장의 주요 요인으로 작용하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

• 시장 세분화와 범위
• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 기술 진보
  • AI와 디지털 기술 통합
• 가격 모델 분석
• 임상시험 건수 분석, 2024년
• 시장 분석 툴
  • Porter의 Five Forces 분석
  • SWOT 분석에 의한 PESTEL
  • COVID-19의 영향 분석

제4장 임상시험 공급 및 물류 시장 : 서비스 추정·동향 분석

• 임상시험 공급 및 물류 시장(서비스별) : 부문 대시보드
• 임상시험 공급 및 물류 시장(서비스별) : 변동 분석
• 서비스별, 2018년-2030년
• 물류 및 유통
  • 시장 추정과 부문 예측, 2018-2030년
• 보관 및 유지
  • 시장 추정과 부문 예측, 2018-2030년
• 포장, 라벨 및 블라인드
  • 시장 추정과 부문 예측, 2018-2030년
• 제조업
  • 시장 추정과 부문 예측, 2018-2030년
• 비교 조달
  • 시장 추정과 부문 예측, 2018-2030년
• 기타 서비스
  • 시장 추정과 부문 예측, 2018-2030년

제5장 임상시험 공급 및 물류 시장 : Phase 추정·동향 분석

• 임상시험 공급 및 물류 시장(Phase별) : 부문 대시보드
• 임상시험 공급 및 물류 시장(Phase별) : 변동 분석
• Phase별, 2018년-2030년
• Phase I
  • 시장 추정과 부문 예측, 2018-2030년
• Phase II
  • 시장 추정과 부문 예측, 2018-2030년
• Phase III
  • 시장 추정과 부문 예측, 2018-2030년
• Phase IV
  • 시장 추정과 부문 예측, 2018-2030년

제6장 임상시험 공급 및 물류 시장 : 치료 영역 추정·동향 분석

• 임상시험 공급 및 물류 시장(치료 영역별) : 부문 대시보드
• 임상시험 공급 및 물류 시장(치료 영역별) : 변동 분석
• 치료 영역별, 2018년-2030년
• 종양학
  • 시장 추정과 부문 예측, 2018-2030년
• 심혈관 질환
  • 시장 추정과 부문 예측, 2018-2030년
• 호흡기 질환
  • 시장 추정과 부문 예측, 2018-2030년
• 중추신경계 및 정신질환
  • 시장 추정과 부문 예측, 2018-2030년
• 기타
  • 시장 추정과 부문 예측, 2018-2030년

제7장 임상시험 공급 및 물류 시장 : 최종 용도 추정·동향 분석

• 임상시험 공급 및 물류 시장(최종 용도별) : 부문 대시보드
• 임상시험 공급 및 물류 시장(최종 용도별) : 변동 분석
• 최종 용도별, 2018년-2030년
• 의약품
  • 시장 추정과 부문 예측, 2018-2030년
• 생물제제
  • 시장 추정과 부문 예측, 2018-2030년
• 의료기기
  • 시장 추정과 부문 예측, 2018-2030년

제8장 임상시험 공급 및 물류 시장 : 지역 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년 및 2030년
• 지역 시장 대시보드
• 세계 지역 시장 스냅숏
• 북미
  • 북미 시장 추정과 부문 예측, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽 시장 추정과 부문 예측, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양 시장 추정과 부문 예측, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 라틴아메리카 시장 추정과 부문 예측, 2018-2030년
  • 브라질
  • 아르헨티나
  • 콜롬비아
• 중동 및 아프리카
  • 중동 및 아프리카 시장 추정과 부문 예측, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제9장 경쟁 구도

• 기업 분류
  • 마켓 리더
  • 신규 기업
• 기업 개요
  • Thermo Fisher Scientific Inc.
  • UPS Healthcare
  • Piramal Pharma Solutions
  • DHL
  • Parexel International
  • Almac Group
  • Movianto
  • UDG Healthcare
  • FedEx
  • Catalent, Inc.

LSH

영문 목차

영문목차

Clinical Trial Supply & Logistics Market Growth & Trends:

The global clinical trials supply & logistics market size is estimated to reach USD 6.72 billion by 2030, expanding at a CAGR of 7.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.

Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.

There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.

Clinical Trial Supply & Logistics Market Report Highlights:

• In service segment, logistics & distribution dominated the market in 2024 with a share of 25.3%. This is due to the rise in clinical trials due to COVID- 19 pandemic
• Based on phase, The phase III segment accounted for the largest revenue share in 2024
• Based on therapeutic area, the cardiovascular diseases segment held the largest market share in 2024. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market
• North America dominated the market with a revenue share of 38.33% in 2024.The region accounts for the highest number of clinical trials conducted among all regions, which is a major driver for growth of clinical trial supply and logistics market.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Region Wise Market: Base Estimates
  • 1.5.2. Global Market: CAGR Calculation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
  • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.6.4. Bottom-Up Approach (Model 4)
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Technological Advancements in Supply Chain
    • 3.3.1.2. Increasing R&D Investment by Pharmaceutical and Biopharmaceutical Firms
    • 3.3.1.3. Increasing Demand For Outsourcing Services Across The Developing Economies
    • 3.3.1.4. Expansion of Clinical Trial Sites
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Stringent Regulation Pertaining to Logistics
    • 3.3.2.2. Counterfeiting of Drugs
• 3.4. Technological Advancements
  • 3.4.1. Integration of AI and Digital Technologies
• 3.5. Pricing Model Analysis
• 3.6. Clinical Trials Volume Analysis, 2024
  • 3.6.1. Total Number of Clinical Trials, by Region (2024)
  • 3.6.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.6.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.6.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL by SWOT Analysis
  • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supply & Logistics Market: Service Estimates & Trend Analysis

• 4.1. Clinical Trial Supply & Logistics Market, By Service: Segment Dashboard
• 4.2. Clinical Trial Supply & Logistics Market, By Service: Movement Analysis
• 4.3. Clinical Trial Supply & Logistics Market Estimates & Forecasts, By Service, 2018 - 2030
• 4.4. Logistics & Distribution
  • 4.4.1. Logistics & Distribution Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.5. Storage & Retention
  • 4.5.1. Storage & Retention Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.6. Packaging, Labeling, and Blinding
  • 4.6.1. Packaging, Labeling, and Blinding Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.7. Manufacturing
  • 4.7.1. Manufacturing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.8. Comparator Sourcing
  • 4.8.1. Comparator Sourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.9. Other Services
  • 4.9.1. Other Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Supply & Logistics Market: Phase Estimates & Trend Analysis

• 5.1. Clinical Trial Supply & Logistics Market, By Phase: Segment Dashboard
• 5.2. Clinical Trial Supply & Logistics Market, By Phase: Movement Analysis
• 5.3. Clinical Trial Supply & Logistics Market Estimates & Forecasts, By Phase, 2018 - 2030
• 5.4. Phase I
  • 5.4.1. Phase I Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.5. Phase II
  • 5.5.1. Phase II Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.6. Phase III
  • 5.6.1. Phase III Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.7. Phase IV
  • 5.7.1. Phase IV Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Supply & Logistics Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Clinical Trial Supply & Logistics Market, By Therapeutic Area: Segment Dashboard
• 6.2. Clinical Trial Supply & Logistics Market, By Therapeutic Area: Movement Analysis
• 6.3. Clinical Trial Supply & Logistics Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
• 6.4. Oncology
  • 6.4.1. Oncology Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.5. Cardiovascular Diseases
  • 6.5.1. Cardiovascular Diseases Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.6. Respiratory Diseases
  • 6.6.1. Respiratory Diseases Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.7. CNS and Mental Disorders
  • 6.7.1. CNS and Mental Disorders Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Supply & Logistics Market: End Use Estimates & Trend Analysis

• 7.1. Clinical Trial Supply & Logistics Market, By End Use: Segment Dashboard
• 7.2. Clinical Trial Supply & Logistics Market, By End Use: Movement Analysis
• 7.3. Clinical Trial Supply & Logistics Market Estimates & Forecasts, By End Use, 2018 - 2030
• 7.4. Pharmaceuticals
  • 7.4.1. Pharmaceuticals Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.5. Biologicals
  • 7.5.1. Biologicals Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.6. Medical Device
  • 7.6.1. Medical Device Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Clinical Trial Supply & Logistics Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Denmark Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Sweden Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Japan Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. China Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Thailand Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.7.4. Colombia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Colombia Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Clinical Trial Supply & Logistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Profiles
  • 9.2.1. Thermo Fisher Scientific Inc.
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Service Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. UPS Healthcare
    • 9.2.2.1. Company Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Service Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. Piramal Pharma Solutions
    • 9.2.3.1. Company Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Service Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. DHL
    • 9.2.4.1. Company Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Service Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. Parexel International
    • 9.2.5.1. Company Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Service Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. Almac Group
    • 9.2.6.1. Company Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Service Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. Movianto
    • 9.2.7.1. Company Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Service Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. UDG Healthcare
    • 9.2.8.1. Company Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Service Benchmarking
    • 9.2.8.4. Strategic Initiatives
  • 9.2.9. FedEx
    • 9.2.9.1. Company Overview
    • 9.2.9.2. Financial Performance
    • 9.2.9.3. Service Benchmarking
    • 9.2.9.4. Strategic Initiatives
  • 9.2.10. Catalent, Inc.
    • 9.2.10.1. Company Overview
    • 9.2.10.2. Financial Performance
    • 9.2.10.3. Service Benchmarking
    • 9.2.10.4. Strategic Initiatives

관련자료